Search results

Company Profile(Page)
Medicortex Finland Medicortex Finland Oy was founded in June 2014 as a BioTurku member; its laboratories are located in the Turku Science Park...

Medicortex Finland Is Developing Diagnostic Tool Based on Biomarkers for Traumatic Brain Injury and Stroke(News)
Medicortex Finland's new press release is out! Medicortex Finland Oy has started research to establish a biomarker and to develop a diagno...

Business Strategy(Page)
Business Strategy Medicortex is determined to become a revolutionary biotech company. Today, no accurate diagnosis for TBI exists, and diagnos...

In the Press(Page)
Medicortex Finland in the Press Medicortex Finland Oy: Clinical Trial Extended for Detection of Mild Traumatic Brain Injury In Business Wire N...

Medicortex Finland Announces Agreement with Pro-Lab / Yhteistyösopimus Pro-Lab:n kanssa(News)
Medicortex has signed a cooperation agreement with a Canadian company Pro-Lab Diagnostics Inc. Please see the...

Medicortex in Good News Finland(Page)
Medicortex's CEO Adrian Harel was interviewed by Good News Finland. The whole article can be viewed  here Depositphotos 12063912 Small...

Science Park Medicortex Finland(Page)
in Turku a company called Medicortex Finland which develops drugs for reducing the impacts of traumatic brain injury and diagnostics for deter...

Board and Management(Page)
anagement Management Team Medicortex's CEO, Dr. , holds a PhD in Neurobiology, from the Weizmann Institute of Science, and was a postdoctoral ...

Tutkimussuunnitelma(Page)
eamiseen ei ole olemassa. Medicortexin tavoitteena on kehittää biologisiin merkkiaineisiin perustuva testausjärjestelmä, jota voitaisiin käytt...

Art auction(Page)
About this auction Medicortex Finland medico_47c9da6_row_2.png medico_54b8af0_row_3.png Medicortex has started to raise funds for the developm...

Technology(Page)
or explosion injuries.   Medicortex will be the first biomarker from a non-invasive sample of body fluid approved by regulatory agencies for ...

Clinical Trial Result Marks a Significant Accomplishment for Medicortex Finland(News)
remarkable milestone for Medicortex. Please see the ...

Tom Palenius joins Medicortex's Board of Directors(News)
Annual General Meeting of Medicortex, held on 29th May 2017, elected Mr. Tom Palenius as the member of the Board of Directors. Mr. Palenius ha...

Mayor of Turku visiting Medicortex / Turun kaupunginjohtaja vierailulla(News)
he City of Turku, visited Medicortex today. Medicortex's projects and background as well as the company's team were presented her. We had plea...

Medicortex Finland Oy: Clinical Trial Extended for Detection of Mild Traumatic Brain Injury(News)
Medicortex was authorized by the ethical committee to add a new study site to the current clinical trial. The company is now conducting th...

Suomeksi(Page)
Suomeksi Medicortex Finland Oy on tapaturmaisen aivovamman biomerkkiainetutkimukseen erikoistunut yritys. Medicortexin ensimmäinen tavoite on ...

Why to invest?(Page)
Why to invest in Medicortex Finland Oy? Medicortex is introducing, in Finland, a new diagnostic method for a huge need – detection of brain in...

Miksi sijoittaa?(Page)
Miksi sijoittaa Medicortexiin? Medicortex kehittää Suomessa uutta menetelmää suureen tarpeeseen eli tapaturmaisen aivovamman diagnosointiin Si...

Medicortex Finland Receives an Innovation Grant(News)
Medicortex Finland Oy has received an innovation grant from the Runar Bäckström foundation for the development of a diagnostic ki...

Art Helping TBI Research(News)
Medicortex Finland Oy has started to raise funds for the development of a diagnostic kit for peopl...

Medicortex received an innovation award(News)
kström foundation awarded Medicortex an innova...

Newsletter 2/2017: Three questions about the Medicortex's idea(News)
Medicortex's crowdfunding at Invesdor is going on and we have received a lot of questions regarding the idea. We would like to answer three ma...

Military accidents can be diagnosed using Medicortex's kit - A new press release(News)
raumatic stress disorder. Medicortex's kit can help to find the actual reason for their problems...

Article in Turun Sanomat about Medicortex Finland Oy / Turun Sanomissa artikkeli Medicortexista(News)
rticle and interview with Medicortex team.Turun Sanomissa oli tänään artikkeli ja haastattelu Medicortexista...

Medicortex was accepted to the European Union Horizon 2020 funding program (News)
Medicortex was accepted to the first phase of the European Union...

Medicortex is featured in Good News from Finland / Medicortex näkyvästi esillä Good News from Finland -sivustolla(News)
Medicortex is one of a few Finnish beneficiaries of the 50,000-euro grant from the European Innovation Council. See an article on...

Kansanterveys(Page)
erveys-julkaisu esittelee Medicortex Finlandin mahdollisuuksia. Tapaturmainen aivovamma ja krooninen traumaattinen enkefalopatia (Chronic Trau...

Investment agreement(Page)
canned copy by e-mail to: medicortex@medicortex.fi Or by post to: Medicortex Finland Oy Itäinen Pitkäkatu 4 B, 4th floor 20520 Turku FINLAND B...

Medicortex Finland Held Discussions with TEKES(News)
Medicortex Finland's staff was in Helsinki on the 7th of March to discuss a long-term loan with the ...

Medicortex is attenting BAF Live! in April(News)
l & Mårten Kvist from Medicortex Finland are attending the...

Medicortex presenting at the Sport Concussion Symposium in Helsinki(News)
text" target="_blank">Medicortex will have a poster presentation in the Symposium...

Medicortex Finland featured on The Bio Connection(News)
Medicortex Finland's was featured on March 28th on The Bio Connection news site. You can read the article in full...

Medicortex's Annual General Meeting on May 30th(News)
Medicortex's annual general meeting will take place in the Turku Science Park Bioincubator on the 30th of May. All shareholders are invite...

Press release: A clinical trial is a significant accomplishment for Medicortex(News)
ficant-accomplishment-for-medicortex?publisherId=49600577&releaseId=50277257" class="">press release about the clinical trial...

Medicortex Featured in Local Newspaper, Turun Sanomat(News)
Medicortex's Adrian Harel & Mårten Kvist were interviewed by Turun Sanomat during the holiday season. Dr. Harel discussed the...

Medicortex has launched a crowdfunding campaign(News)
Medicortex has started a crowdfunding campaign to finance the next phase development of the brain injury test. You can help us to develop...

Medicortex Finland using crowdfunding to help develop brain injury diagnostics(News)
/pressreleasejet.com/news/medicortex-finland-using-crowdfunding-to-help-develop-brain-injury-diagnostics.html" class="aloha-link-text" target=...

Medicortex's Annual General Meeting on May 29th(News)
Medicortex's Annual General meeting will take place in The Turku Science Park Bioincubator on the 29th of May 2017 at 15:00. All current s...

Medicortex participated in a press conference #pääasia(News)
Medicortex's medical director Mårten Kvist participated on a panel discussion of #pääasia- media event 7.11. in Biocity Turku. Fo...

Medicortex presentation in Monaco (News)
by Dr. Adrian Harel from Medicortex Finland Oy in Monaco (September 28, 2018 - Novotel Monte Carlo).For more information and sign...

Investors(Page)
is 5 000 € (1000 shares). Medicortex Investor Notice 2018 Why to invest in a nutshell How the Medicortex test kit would benefit people Get to ...

Biomarker R&D program(Page)
Biomarker R&D program Poc Medicortex has performed preclinical research. The results showed some unique biomarkers released as biodegradation ...

Scientific advisory board gather together first time in a new composition (News)
Medicortex Finland Oy scientific advisory board gather together first time with a new composition. We had active di...

Approval of a patent for a drug candidate / Lääkemolekyylipatentti hyväksytty(News)
Medicortex has been granted a patent in Finland and in the USA for its drug molecule candidates. Please see our...

The second brain injury awareness meeting 12.2.2018(News)
eness evening was held in Medicortex premises on February 12th 2018. Dr. Lauri Kangas, Member of the Scientific Advisory Board, opened the eve...

Our Vision(Page)
Our Vision Medicortex’s aim is to develop a simple, easy-to-use and relatively cheap test based on a biomarker found in one of the body fluids...

Professor Asla Pitkänen is the Neuroscientist of the Year(News)
Member of the Medicortex's Scientific Advisory Board, Professor Asla Pitkänen was awarded a title of Neuroscientist of the...

New Clinical Trial Started / Kliininen tutkimus alkanut(News)
Medicortex announces that the first subject has been enrolled in the new clinical trial. Please see the...

Ota yhteyttä(Page)
ta yhteyttä ja kysy lisää Medicortex Finland Oy PharmaCity Itäinen pitkäkatu 4 B, 4. kerros 20520 Turku Finland Tel. +358 (0)400 488 817 adria...

Executive summary(Page)
cutive summary Yhtiöesite Medicortex Executive Summary Oct 2018 Medicortex Esite Lokakuu 2018 Executive summary...

Science(Page)
Diego Ph 249471 Copy Crop Medicortex has discovered new biomarkers that have never been studied before for detection of TBI, identifying them ...

Proof of concept(Page)
mans Pre-clinical studies Medicortex has performed preclinical research comparing fluid biopsies from normal and injured lab animals. The resu...

Crowdfunding successfully completed / Joukkorahoituskampnaja päättynyt(News)
Medicortex has reached the target amount in the crowdfunding campaign using Invesdor's platform. We have more than 80 new shareholders sup...

Scientific Advisory Board (SAB) had a meeting(News)
p>The Scientific Advisory...

A New Clinical Trial for a Novel Brain Injury Biomarker(News)
Medicortex Finland Oy was granted clearance to begin a multi-center clinical trial. The trial will consist of patients that are admitted t...

Third study site has been added to the clinical trial (News)
ct2/show/NCT03306563?term=medicortex&rank=1" class="aloha-link-text" target="_blank">ClinicalTrials database. Vaasa central hospi...

Articles(Page)
w article compiled by the Medicortex team on the diagnostic biomarkers of TBI. Harel Et Al 2016 Biomarkers Of Tbi   Published in International...

Clinical trials(Page)
s later in 2017. Phase II Medicortex is running and planning the following clinical trials. Clinical trials...

Head injuries in sports and army(Page)
rts and army See here how Medicortex kit would benefit active young adults and professional athletes. Or how it would benefit the military per...

Drug development program(Page)
ue chemical spacers allow Medicortex to create medication that has the ability to stop the post-TBI cascade. It should be noted that all of th...

Second clinical trial(Page)
Second clinical trials Medicortex started in Q4/2017 a large clinical study in collaboration with two Finnish hospitals. Patients with a suspe...

Yhtiön esite (Page)
oint -esitys Yhtiöesite:  Medicortex Esite Elokuu 2018 Yhtiön Power Point -esitys: Yhtiön esite...

Dr. Harel is the Face of the Month in Turku Science Park's Newsletter(News)
in Turku a company called Medicortex Finland which develops drugs for reducing the impacts of traumatic brain injury and diagnostics for deter...

Dr. Harel Is Attending Biotech and Money London 2016 (News)
arel will be representing Medicortex Finland in the UK as he is attending the 2nd annual Biotech and Money event in London. The event takes pl...

Dr. Adrian Harel Presented TBI at Life Sciences Israel 2015(News)
n 18th and 19th February. Medicortex Finland and Traumatic Brain Injury were presented. The event page can be found ...

The First Clinical Trial is Approaching(News)
Medicortex is planning to conduct a clinical trial in the Q4 of 2016. The presence and the profiles of the unique biomarkers will be studi...

Extraordinary general meeting 29th September(News)
details from adrian.harel@medicortex.fi...

BAF Live! in Helsinki 22nd October 2015(News)
etventure.com/en/projects/medicortex-finland-oy#.ViiugX4rLIU" class="" target="_blank">the company pitch page here. ...

Drs. Harel & Kvist attended the BAF Live! event in Helsinki on 22nd of October(News)
he event was a success as Medicortex was the first company to present itself and the company is ranked #1 in the event's social media activity...

A review article was published(News)
The Medicortex team has written a scientific review article focusing on the latest research on TBI biomarkers. The article was published i...

Dr. Harel presenting at ESTES Congress 2017(News)
Medicortex's poster abstract has been nominated for the Best Poster Award in the...

Development of the brain injury test sped up by crowdfunding(News)
clinical trial encouraged Medicortex to move on to the next phase in the diagnostic kit development program. We are raising money through the...

An interview published(News)
ity got interested in the Medicortex's clinical activities. Please see Dr. Harel being interviewed by...

Onnea satavuotias Suomi!(News)
tsenäisyyspäivää kaikille Medicortexin seuraajille ja omistajille! Upeat 100 itsenäistä vuotta ovat tehneet Suomesta maailman parhaan paikan e...

Annual General Meeting on 30th May / Varsinainen yhtiökokous 30.5.(News)
Medicortex's Annual General Shareholders' meeting will be held on 30th May 2018 at 3.00 p.m. in the premises of the company in Tu...

Kansanterveys-julkaisu esittelee Medicortexin mahdollisuuksia(News)
...

Press release: Medicortex Finland Oy hakee rahoitusta aivovammatestin kehittämiseen(News)
Please see our press release...

Medicortex has completed collection of clinical samples(News)
We are happy to announce that we have completed the collection of clinical TBI patient samples in collaboration with Turku University Hosp...

Medicortex presentation in Monaco (News)
Dr. Harel will be presenting at an investors meeting in Monaco. For more information please look at the link. ...